Advertisement

Index by author

December 01, 2019; Volume 371,Issue 3

A

  1. Abe, Taiki

    1. Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism
      Taiki Abe, Ryota Shizu, Takamitsu Sasaki, Yuki Shimizu, Takuomi Hosaka, Susumu Kodama, Atsushi Matsuzawa and Kouichi Yoshinari
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 590-601; DOI: https://doi.org/10.1124/jpet.119.258632

  2. Agrimi, Jacopo

    1. Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca2+-Activated Force and Thus Contractility in the Failing Myocardium
      Tao Meng, Xianfeng Ren, Xinzhong Chen, Jingui Yu, Jacopo Agrimi, Nazareno Paolocci and Wei Dong Gao
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 615-623; DOI: https://doi.org/10.1124/jpet.119.259556

  3. Alaaeddine, Rana

    1. Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh, Hosny Fouad, Evan I. Saad, Marwan E. El-Sabban, Frances Plane and Ahmed F. El-Yazbi
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 567-582; DOI: https://doi.org/10.1124/jpet.119.262048

B

  1. Barreto de Moura, Fernando

    1. Enhancement of Opioid Antinociception by Nicotine
      Fernando Barreto de Moura, Sarah Louise Withey and Jack Bergman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 624-632; DOI: https://doi.org/10.1124/jpet.119.261438

  2. Baumann, Michael H.

    1. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
      Chloe J. Jordan, Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman and Charles W. Schindler
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 602-614; DOI: https://doi.org/10.1124/jpet.119.259390

  3. Bergman, Jack

    1. Enhancement of Opioid Antinociception by Nicotine
      Fernando Barreto de Moura, Sarah Louise Withey and Jack Bergman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 624-632; DOI: https://doi.org/10.1124/jpet.119.261438

  4. Blanco, Isabella K.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  5. Buchanan, Fritz G.

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

  6. Burnett, James C.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

C

  1. Cashman, John R.

    1. A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer
      Jiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, Dong-Hoon Lee, Karl J. Okolotowicz and John R. Cashman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 703-712; DOI: https://doi.org/10.1124/jpet.119.261040

  2. Chen, Xinzhong

    1. Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca2+-Activated Force and Thus Contractility in the Failing Myocardium
      Tao Meng, Xianfeng Ren, Xinzhong Chen, Jingui Yu, Jacopo Agrimi, Nazareno Paolocci and Wei Dong Gao
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 615-623; DOI: https://doi.org/10.1124/jpet.119.259556

  3. Cheng, Dong

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

  4. Cheng, Jiongjia

    1. A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer
      Jiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, Dong-Hoon Lee, Karl J. Okolotowicz and John R. Cashman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 703-712; DOI: https://doi.org/10.1124/jpet.119.261040

  5. Cheng, Min

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

D

  1. Dorner-Ciossek, Cornelia

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

E

  1. El-Sabban, Marwan E.

    1. Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh, Hosny Fouad, Evan I. Saad, Marwan E. El-Sabban, Frances Plane and Ahmed F. El-Yazbi
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 567-582; DOI: https://doi.org/10.1124/jpet.119.262048

  2. El-Yazbi, Ahmed F.

    1. Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh, Hosny Fouad, Evan I. Saad, Marwan E. El-Sabban, Frances Plane and Ahmed F. El-Yazbi
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 567-582; DOI: https://doi.org/10.1124/jpet.119.262048

  3. Elkhatib, Mohammed A.W.

    1. Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh, Hosny Fouad, Evan I. Saad, Marwan E. El-Sabban, Frances Plane and Ahmed F. El-Yazbi
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 567-582; DOI: https://doi.org/10.1124/jpet.119.262048

  4. Enomoto, Takeshi

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

F

  1. Fedele, Ernesto

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  2. Fouad, Hosny

    1. Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh, Hosny Fouad, Evan I. Saad, Marwan E. El-Sabban, Frances Plane and Ahmed F. El-Yazbi
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 567-582; DOI: https://doi.org/10.1124/jpet.119.262048

  3. Fuchs, Holger

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  4. Fujii, Yuki

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

G

  1. Gao, Lie

    1. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure
      Changhai Tian, Lie Gao, Andi Zhang, Bryan T. Hackfort and Irving H. Zucker
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 642-651; DOI: https://doi.org/10.1124/jpet.119.261792

  2. Gao, Wei Dong

    1. Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca2+-Activated Force and Thus Contractility in the Failing Myocardium
      Tao Meng, Xianfeng Ren, Xinzhong Chen, Jingui Yu, Jacopo Agrimi, Nazareno Paolocci and Wei Dong Gao
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 615-623; DOI: https://doi.org/10.1124/jpet.119.259556

  3. Gao, Wenqing

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

  4. Garrott, Sharon R.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  5. Giovannini, Riccardo

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  6. Goda, Masao

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

  7. Gomez-Galeno, Jorge

    1. A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer
      Jiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, Dong-Hoon Lee, Karl J. Okolotowicz and John R. Cashman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 703-712; DOI: https://doi.org/10.1124/jpet.119.261040

  8. Guo, Jun

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

H

  1. Hackfort, Bryan T.

    1. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure
      Changhai Tian, Lie Gao, Andi Zhang, Bryan T. Hackfort and Irving H. Zucker
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 642-651; DOI: https://doi.org/10.1124/jpet.119.261792

  2. Hart, Duncan J.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  3. Hashimoto, Takashi

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

  4. Hosaka, Takuomi

    1. Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism
      Taiki Abe, Ryota Shizu, Takamitsu Sasaki, Yuki Shimizu, Takuomi Hosaka, Susumu Kodama, Atsushi Matsuzawa and Kouichi Yoshinari
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 590-601; DOI: https://doi.org/10.1124/jpet.119.258632

  5. Hsu, Ku-Lung

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  6. Huang, Anthony Y.

    1. Immune Responses Alter Taste Perceptions: Immunomodulatory Drugs Shape Taste Signals during Treatments
      Anthony Y. Huang
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 684-691; DOI: https://doi.org/10.1124/jpet.119.261297

  7. Humburg, Bree A.

    1. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
      Chloe J. Jordan, Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman and Charles W. Schindler
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 602-614; DOI: https://doi.org/10.1124/jpet.119.259390

I

  1. Ikeda, Kazuhito

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

  2. Io, Fusayo

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

J

  1. Javitt, Norman B.

    1. Hepatic Bile Formation: Canalicular Osmolarity and Paracellular and Transcellular Water Flow
      Raul A. Marinelli, Mary Vore and Norman B. Javitt
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 713-717; DOI: https://doi.org/10.1124/jpet.119.261115

  2. Jiang, Zhen

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

  3. Jordan, Chloe J.

    1. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
      Chloe J. Jordan, Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman and Charles W. Schindler
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 602-614; DOI: https://doi.org/10.1124/jpet.119.259390

K

  1. Kamada, Mami

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

  2. Kato, Sota

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

  3. Kitamura, Atsushi

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

  4. Kodama, Susumu

    1. Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism
      Taiki Abe, Ryota Shizu, Takamitsu Sasaki, Yuki Shimizu, Takuomi Hosaka, Susumu Kodama, Atsushi Matsuzawa and Kouichi Yoshinari
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 590-601; DOI: https://doi.org/10.1124/jpet.119.258632

  5. Koretsune, Hiroko

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

  6. Koros, Eliza

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  7. Kunioka, Ei-ichi

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

L

  1. Lazo, John S.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  2. Lee, Dong-Hoon

    1. A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer
      Jiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, Dong-Hoon Lee, Karl J. Okolotowicz and John R. Cashman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 703-712; DOI: https://doi.org/10.1124/jpet.119.261040

  3. Li, Daxiang

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

  4. Li, Tao

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

M

  1. Marinelli, Raul A.

    1. Hepatic Bile Formation: Canalicular Osmolarity and Paracellular and Transcellular Water Flow
      Raul A. Marinelli, Mary Vore and Norman B. Javitt
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 713-717; DOI: https://doi.org/10.1124/jpet.119.261115

  2. Marti, Anelise

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  3. Matsuzawa, Atsushi

    1. Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism
      Taiki Abe, Ryota Shizu, Takamitsu Sasaki, Yuki Shimizu, Takuomi Hosaka, Susumu Kodama, Atsushi Matsuzawa and Kouichi Yoshinari
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 590-601; DOI: https://doi.org/10.1124/jpet.119.258632

  4. McCloud, Rebecca L.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  5. Meng, Tao

    1. Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca2+-Activated Force and Thus Contractility in the Failing Myocardium
      Tao Meng, Xianfeng Ren, Xinzhong Chen, Jingui Yu, Jacopo Agrimi, Nazareno Paolocci and Wei Dong Gao
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 615-623; DOI: https://doi.org/10.1124/jpet.119.259556

  6. Moore, Stephanie

    1. A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer
      Jiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, Dong-Hoon Lee, Karl J. Okolotowicz and John R. Cashman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 703-712; DOI: https://doi.org/10.1124/jpet.119.261040

  7. Mroueh, Ali

    1. Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh, Hosny Fouad, Evan I. Saad, Marwan E. El-Sabban, Frances Plane and Ahmed F. El-Yazbi
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 567-582; DOI: https://doi.org/10.1124/jpet.119.262048

  8. Mudd, Sarah R.

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

N

  1. Newman, Amy Hauck

    1. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
      Chloe J. Jordan, Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman and Charles W. Schindler
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 602-614; DOI: https://doi.org/10.1124/jpet.119.259390

  2. Nishigori, Kantaro

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

  3. Nishizato, Yohei

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

O

  1. Ochiai, Nagahiro

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

  2. Okolotowicz, Karl J.

    1. A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer
      Jiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, Dong-Hoon Lee, Karl J. Okolotowicz and John R. Cashman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 703-712; DOI: https://doi.org/10.1124/jpet.119.261040

P

  1. Paolocci, Nazareno

    1. Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca2+-Activated Force and Thus Contractility in the Failing Myocardium
      Tao Meng, Xianfeng Ren, Xinzhong Chen, Jingui Yu, Jacopo Agrimi, Nazareno Paolocci and Wei Dong Gao
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 615-623; DOI: https://doi.org/10.1124/jpet.119.259556

  2. Pierre, Sandrine V.

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

  3. Plane, Frances

    1. Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh, Hosny Fouad, Evan I. Saad, Marwan E. El-Sabban, Frances Plane and Ahmed F. El-Yazbi
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 567-582; DOI: https://doi.org/10.1124/jpet.119.262048

Q

  1. Qi, Yiyao

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

R

  1. Rastelli, Ettore J.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  2. Ren, Xianfeng

    1. Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca2+-Activated Force and Thus Contractility in the Failing Myocardium
      Tao Meng, Xianfeng Ren, Xinzhong Chen, Jingui Yu, Jacopo Agrimi, Nazareno Paolocci and Wei Dong Gao
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 615-623; DOI: https://doi.org/10.1124/jpet.119.259556

  3. Reymann, Klaus G.

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  4. Rosenbrock, Holger

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  5. Runge, Frank

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

S

  1. Saad, Evan I.

    1. Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Impaired Endothelium-Dependent Hyperpolarization Underlies Endothelial Dysfunction during Early Metabolic Challenge: Increased ROS Generation and Possible Interference with NO Function
      Rana Alaaeddine, Mohammed A.W. Elkhatib, Ali Mroueh, Hosny Fouad, Evan I. Saad, Marwan E. El-Sabban, Frances Plane and Ahmed F. El-Yazbi
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 567-582; DOI: https://doi.org/10.1124/jpet.119.262048

  2. Sasaki, Takamitsu

    1. Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism
      Taiki Abe, Ryota Shizu, Takamitsu Sasaki, Yuki Shimizu, Takuomi Hosaka, Susumu Kodama, Atsushi Matsuzawa and Kouichi Yoshinari
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 590-601; DOI: https://doi.org/10.1124/jpet.119.258632

  3. Schänzle, Gerhard

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  4. Schindler, Charles W.

    1. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
      Chloe J. Jordan, Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman and Charles W. Schindler
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 602-614; DOI: https://doi.org/10.1124/jpet.119.259390

  5. Schröder, Ulrich H.

    1. Open Access
      The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
      Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koros, Frank Runge, Holger Fuchs, Anelise Marti, Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele and Cornelia Dorner-Ciossek
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 633-641; DOI: https://doi.org/10.1124/jpet.119.260059

  6. Shaik, Anver Basha

    1. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
      Chloe J. Jordan, Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman and Charles W. Schindler
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 602-614; DOI: https://doi.org/10.1124/jpet.119.259390

  7. Sharlow, Elizabeth R.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  8. Shimizu, Yuki

    1. Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism
      Taiki Abe, Ryota Shizu, Takamitsu Sasaki, Yuki Shimizu, Takuomi Hosaka, Susumu Kodama, Atsushi Matsuzawa and Kouichi Yoshinari
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 590-601; DOI: https://doi.org/10.1124/jpet.119.258632

  9. Shizu, Ryota

    1. Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism
      Taiki Abe, Ryota Shizu, Takamitsu Sasaki, Yuki Shimizu, Takuomi Hosaka, Susumu Kodama, Atsushi Matsuzawa and Kouichi Yoshinari
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 590-601; DOI: https://doi.org/10.1124/jpet.119.258632

T

  1. Taga, Shiori

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

  2. Takano, Hiroki

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

  3. Takayama, Noriko

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

  4. Tasker, Nikhil R.

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  5. Tatara, Ayaka

    1. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
      Takeshi Enomoto, Ayaka Tatara, Masao Goda, Yohei Nishizato, Kantaro Nishigori, Atsushi Kitamura, Mami Kamada, Shiori Taga, Takashi Hashimoto, Kazuhito Ikeda and Yuki Fujii
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 692-702; DOI: https://doi.org/10.1124/jpet.119.260869

  6. Thorndike, Eric B.

    1. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
      Chloe J. Jordan, Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman and Charles W. Schindler
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 602-614; DOI: https://doi.org/10.1124/jpet.119.259390

  7. Tian, Changhai

    1. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure
      Changhai Tian, Lie Gao, Andi Zhang, Bryan T. Hackfort and Irving H. Zucker
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 642-651; DOI: https://doi.org/10.1124/jpet.119.261792

  8. Tse, Chris

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

U

  1. Uchida, Saeko

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

V

  1. Voorbach, Martin J.

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

  2. Vore, Mary

    1. Hepatic Bile Formation: Canalicular Osmolarity and Paracellular and Transcellular Water Flow
      Raul A. Marinelli, Mary Vore and Norman B. Javitt
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 713-717; DOI: https://doi.org/10.1124/jpet.119.261115

W

  1. Wan, Xiaochun

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

  2. Wang, Yin

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

  3. Wilsbacher, Julie

    1. Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In Vivo
      Sarah R. Mudd, Martin J. Voorbach, Dong Cheng, Min Cheng, Jun Guo, Wenqing Gao, Fritz G. Buchanan, Chris Tse and Julie Wilsbacher
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 583-589; DOI: https://doi.org/10.1124/jpet.119.259135

  4. Wipf, Peter

    1. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase
      John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 652-662; DOI: https://doi.org/10.1124/jpet.119.262188

  5. Withey, Sarah Louise

    1. Enhancement of Opioid Antinociception by Nicotine
      Fernando Barreto de Moura, Sarah Louise Withey and Jack Bergman
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 624-632; DOI: https://doi.org/10.1124/jpet.119.261438

X

  1. Xi, Zheng-Xiong

    1. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
      Chloe J. Jordan, Bree A. Humburg, Eric B. Thorndike, Anver Basha Shaik, Zheng-Xiong Xi, Michael H. Baumann, Amy Hauck Newman and Charles W. Schindler
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 602-614; DOI: https://doi.org/10.1124/jpet.119.259390

  2. Xie, Zijian

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

  3. Xu, Yunhui

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

Y

  1. Yamamoto, Koji

    1. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
      Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida and Koji Yamamoto
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 675-683; DOI: https://doi.org/10.1124/jpet.119.258731

  2. Yang, Changjun

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

  3. Yoshinari, Kouichi

    1. Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism
      Taiki Abe, Ryota Shizu, Takamitsu Sasaki, Yuki Shimizu, Takuomi Hosaka, Susumu Kodama, Atsushi Matsuzawa and Kouichi Yoshinari
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 590-601; DOI: https://doi.org/10.1124/jpet.119.258632

  4. Yu, Jingui

    1. Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca2+-Activated Force and Thus Contractility in the Failing Myocardium
      Tao Meng, Xianfeng Ren, Xinzhong Chen, Jingui Yu, Jacopo Agrimi, Nazareno Paolocci and Wei Dong Gao
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 615-623; DOI: https://doi.org/10.1124/jpet.119.259556

Z

  1. Zhang, Andi

    1. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure
      Changhai Tian, Lie Gao, Andi Zhang, Bryan T. Hackfort and Irving H. Zucker
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 642-651; DOI: https://doi.org/10.1124/jpet.119.261792

  2. Zhu, Feng

    1. Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
      Yiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li and Sandrine V. Pierre
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 663-674; DOI: https://doi.org/10.1124/jpet.119.260117

  3. Zucker, Irving H.

    1. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure
      Changhai Tian, Lie Gao, Andi Zhang, Bryan T. Hackfort and Irving H. Zucker
      Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 642-651; DOI: https://doi.org/10.1124/jpet.119.261792
Back to top

In this issue

Advertisement